BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23791638)

  • 1. Highly ordered mesoporous carbon nanomatrix as a new approach to improve the oral absorption of the water-insoluble drug, simvastatin.
    Zhang Y; Wang H; Gao C; Li X; Li L
    Eur J Pharm Sci; 2013 Aug; 49(5):864-72. PubMed ID: 23791638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y; Zhi Z; Li X; Gao J; Song Y
    Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A promising nanomatrix system of simvastatin for oral delivery: Evaluation in vitro and in vivo.
    He S; Duan L; Li Y; Cui Z; Zhang X
    Pak J Pharm Sci; 2020 Nov; 33(6):2489-2495. PubMed ID: 33867321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the dissolution rate and oral bioavailability of the poorly water-soluble drug valsartan using novel hierarchical porous carbon monoliths.
    Zhang Y; Che E; Zhang M; Sun B; Gao J; Han J; Song Y
    Int J Pharm; 2014 Oct; 473(1-2):375-83. PubMed ID: 25051114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability.
    Niu X; Wan L; Hou Z; Wang T; Sun C; Sun J; Zhao P; Jiang T; Wang S
    Int J Pharm; 2013 Aug; 452(1-2):382-9. PubMed ID: 23688621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion of celecoxib into fibrous ordered mesoporous carbon for enhanced oral bioavailability and reduced gastric irritancy.
    Zhao P; Jiang H; Jiang T; Zhi Z; Wu C; Sun C; Zhang J; Wang S
    Eur J Pharm Sci; 2012 Apr; 45(5):639-47. PubMed ID: 22251657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the oral bioavailability of simvastatin with silica-lipid hybrid particles: The effect of supersaturation and silica geometry.
    Meola TR; Schultz HB; Peressin KF; Prestidge CA
    Eur J Pharm Sci; 2020 Jul; 150():105357. PubMed ID: 32446169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of solid dispersion of simvastatin.
    Silva TD; Arantes VT; Resende JA; Speziali NL; de Oliveira RB; Vianna-Soares CD
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1348-55. PubMed ID: 20545512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel mesoporous nanomatrix-supported lipid bilayers for oral sustained delivery of the water-insoluble drug, lovastatin.
    Zhang Y; Zhang H; Che E; Zhang L; Han J; Yang Y; Wang S; Zhang M; Gao C
    Colloids Surf B Biointerfaces; 2015 Apr; 128():77-85. PubMed ID: 25731096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization, stability and in vitro-in vivo evaluation of pellet-layered Simvastatin nanosuspensions.
    Luo Y; Xu L; Tao X; Xu M; Feng J; Tang X
    Drug Dev Ind Pharm; 2013 Jul; 39(7):936-46. PubMed ID: 23046250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous carbon with spherical pores as a carrier for celecoxib with needle-like crystallinity: improve dissolution rate and bioavailability.
    Zhu W; Zhao Q; Sun C; Zhang Z; Jiang T; Sun J; Li Y; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():13-20. PubMed ID: 24863191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extruded Soluplus/SIM as an oral delivery system: characterization, interactions, in vitro and in vivo evaluations.
    Zhang Y; Liu Y; Luo Y; Yao Q; Zhong Y; Tian B; Tang X
    Drug Deliv; 2016 Jul; 23(6):1902-11. PubMed ID: 25268150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
    Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
    Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of mesoporous carbon/lipid bilayer nanocomposites for improved oral delivery of the poorly water-soluble drug, nimodipine.
    Zhang Y; Zhao Q; Zhu W; Zhang L; Han J; Lin Q; Ai F
    Pharm Res; 2015 Jul; 32(7):2372-83. PubMed ID: 25609013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation.
    Jiang T; Han N; Zhao B; Xie Y; Wang S
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1230-9. PubMed ID: 22229827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uniform mesoporous carbon as a carrier for poorly water soluble drug and its cytotoxicity study.
    Zhao P; Wang L; Sun C; Jiang T; Zhang J; Zhang Q; Sun J; Deng Y; Wang S
    Eur J Pharm Biopharm; 2012 Apr; 80(3):535-43. PubMed ID: 22193360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
    Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
    Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of a novel starch-derived three-dimensional ordered macroporous carbon for improving the dissolution rate and oral bioavailability of water-insoluble drugs.
    Liu Y; Wu C; Hao Y; Xu J; Zhao Y; Qiu Y; Jiang J; Yu T; Ji P
    J Pharm Biomed Anal; 2016 Jan; 118():267-275. PubMed ID: 26580824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism for increasing the oral bioavailability of poorly water-soluble drugs using uniform mesoporous carbon spheres as a carrier.
    Wang T; Zhao P; Zhao Q; Wang B; Wang S
    Drug Deliv; 2016; 23(2):420-8. PubMed ID: 24870199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.